Exactly tails. By the time the dust settles and MTD is reached, we should have some very compelling data to pursue several very lucrative target markets for many different types of cancers. There is a rhyme and reason to every single person chosen for dosing so far. I've said it before, and I'll say it again - DF is building our foundation right now, we just need to be patient and let the concrete harden so we can start to quickly build on it in the near future.